Vergori A, Lepri AC, Chiuchiarelli M, Mazzotta V, et al. Risk of SARS-CoV-2 infection in patients with hematologic diseases receiving tixagevimab/cilgavimab as pre-exposure prophylaxis in most recent Omicron sublineages era. Int J Infect Dis 2024 Apr 11:107042. doi: 10.1016/j.ijid.2024.107042.
PMID: 38614231